2026-05-20 from ctvnews.ca

LHSC announced Wednesday the largest ever Canadian clinical trial that will test ‘poop pills’ to improve immunotherapy for lung cancer.

“The trial titled LUNA-2 Trial basically looks at investigating the role of FMT which is fecal transplantation in patients with advanced lung cancer,” explained Dr. Jacques Raphael, a scientist with the London Health Sciences Centre Research Institute (LHSCRI).

Researchers said for nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it.

Read more here